Integra Resources receives permit for Wildcat deposit exploration in Nevada

Integra Resources Corp. (NYSE American: ITRG) announced it received final approval of its Exploration Plan of Operations for the Wildcat deposit in Pershing County, Nevada. The approval includes a NEPA Decision Record and Reclamation Permit from federal and state agencies.

The Bureau of Land Management's Humboldt River Field Office submitted the NEPA Decision Record, which authorizes the Final Environmental Assessment and Finding of No Significant Impact for the Wildcat deposit. Nevada's Division of Environmental Protection Bureau of Mining Regulation and Reclamation granted the Reclamation Permit, allowing expanded exploration and development activities.

The Wildcat deposit is part of Integra's Nevada North Project, which also includes the Mountain View gold deposit. The project is located approximately 26 miles west of the company's producing Florida Canyon Mine. Integra previously received approval for an exploration plan for the Mountain View deposit earlier this year.

The approved plan allows for construction of drill roads and pads and expanded drilling programs at Wildcat. The permit includes an initial phase of disturbance with provisions for additional phased expansion subject to bonding and regulatory requirements.

Integra is advancing technical studies to support a Pre-Feasibility Study for Nevada North, with completion targeted for the second half of 2027. The company completed a Preliminary Economic Assessment for the project in 2023, which outlined potential for an open-pit, heap leach gold operation.

"The approval of the Exploration Plan of Operations for Wildcat is a pivotal milestone for Integra," said George Salamis, president and chief executive officer.

The company states it uses cash flow from Florida Canyon Mine to fund advancement of its development projects, including the DeLamar Project in Idaho and the Nevada North Project.

You May Also Be Interested In

• Doncasters (DPC) indicating open around $40, IPO priced at $33
• AIFA signs deals for 57.67% of HyalRoute, targets up to 90% stake
• Supreme Court Shields Bayer From Roundup Cancer-warning Suits